Woodline Partners LP

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
891
Total Value
15376793692
Accession Number
0001172661-25-002043
Form Type
13F-HR
CIK
0001784547
Manager Name
Woodline Partners LP
Data Enrichment
97% identified
867 identified24 unidentified

Holdings

891 positions
Manager:
SEC
Search and click to pin securities to the top
Page 45 of 45
Kalaris Therapeutics, Inc.
KLRS|482929106
Shares:
21519
Value:
$172.8M
Intellia Therapeutics, Inc.
NTLA|45826J105
Shares:
24106
Value:
$171.4M
Mersana Therapeutics, Inc.
MRSN|59045L106
Shares:
435593(+0.0%)
Value:
$149.9M(-75.9%)
Third Harmonic Bio, Inc.
THRD|88427A107
Shares:
40692
Value:
$141.2M
Kezar Life Sciences, Inc.
KZR|49372L209
Shares:
25555
Value:
$124.7M
BioAge Labs, Inc.
BIOA|09077V100
Shares:
31565(-64.3%)
Value:
$118.7M(-76.8%)
Caribou Biosciences, Inc.
CRBU|142038108
Shares:
122135(+0.0%)
Value:
$111.5M(-42.6%)
IGM Biosciences, Inc.
IGMS|449585108
Shares:
69576(+3.4%)
Value:
$80.0M(-80.5%)
BioAtla, Inc.
BCAB|09077B104
Shares:
76324
Value:
$26.5M
Neumora Therapeutics, Inc.
NMRA|640979100
Shares:
14957(-95.2%)
Value:
$15.0M(-99.5%)
SANGAMO THERAPEUTICS, INC
SGMO|800677106
Shares:
19240
Value:
$12.6M